Study of the Efficacy, Safety, and Tolerability of Serlopitant for the Treatment of Refractory Chronic Cough

Study Site 125, Rochester

Study Site 111, Gastonia

Study Site 114, Mooresville

Study Site 103, Charlotte

Study Site 129, Charleston

Study Site 104, Rock Hill

Study Site 107, Winter Park

Study Site 118, Largo

Study Site 122, Cincinnati

Study Site 105, Greenfield

Study Site 115, Plymouth

Study Site 110, Rochester

Study Site 112, Tulsa

Study Site 102, Dallas

Study Site 120, Dallas

Study Site 109, Waco

Study Site 101, San Antonio

Study Site 108, Denver

Study Site 106, Colorado Springs

Study Site 113, Colorado Springs

Study Site 130, Los Angeles

Study Site 123, San Diego

Study Site 128, Mission Viejo

Study Site 127, San Jose

Study Site 131, Stockton

Study Site 116, Portland

Study Site 117, Eugene

Study Site 126, Bellingham

Study Site 121, Ocean Township

Study Site 133, Belfast

Study Site 139, Birmingham

Study Site 136, Cottingham

Study Site 141, Llanelli

Study Site 138, London

Study Site 137, London

Study Site 132, Manchester

Study Site 135, Oxford

Study Site 134, Preston

Study Site 140, Taunton